drugset / Trial / NCT03976063

Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation

NCT03976063

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess whether short-term (48 hr) tocolysis reduces perinatal morti-morbidity in cases of PPROM at 22 to 33 completed weeks' gestation.

Timeline

Start
2019-10-07
Primary completion
2026-11
Completion
2031-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nifedipine Other / unclassified 20 mg Oral